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ABSTRACT
The interferon-induced enzymes 20-50-oligoadeny-
late synthetase (OAS) and RNase L are key compo-
nents of innate immunity involved in sensory and
effector functions following viral infections. Upon
binding target RNA, OAS is activated to produce
20-50-linked oligoadenylates (2-5A) that activate
RNase L, which then cleaves single-stranded self
and non-self RNA. Modified nucleosides that are
present in cellular transcripts have been shown to
suppress activation of several RNA sensors. Here, we
demonstrate that in vitro transcribed, unmodified RNA
activates OAS, induces RNase L-mediated ribosomal
RNA (rRNA) cleavage and is rapidly cleaved by
RNase L. In contrast, RNA containing modified nu-
cleosides activates OAS less efficiently and induces
limited rRNA cleavage. Nucleoside modifications
also make RNA resistant to cleavage by RNase L.
Examining translation in RNase L
 /  cells and mice
confirmed that RNase L activity reduces translation
of unmodified mRNA, which is not observed with
modified mRNA. Additionally, mRNA containing the
nucleoside modification pseudouridine is translated
longer and has an extended half-life. The observa-
tion that modified nucleosides in RNA reduce 2-5A
pathway activation joins OAS and RNase L to the list
of RNA sensors and effectors whose functions are
limited when RNA is modified, confirming the role of
nucleoside modifications in suppressing immune
recognition of RNA.
INTRODUCTION
The antiviral 2-5A system is initiated when double-
stranded (ds)RNA is bound by 20-50-oligoadenylate
synthetases (OAS). There are four OAS genes in
humans, OAS1, OAS2, OAS3 and OASL, encoding 8–10
isoforms due to alternative splicing. Activated OAS (other
than enzymatically inactive OASL) uses ATP as substrate
to produce unique, short 20-50-linked oligomers called
2-5A [px50A(20p50A)n; x=1 3; n 2] that activate the
latent endoribonuclease RNase L. Binding of 2-5A to
the N-terminal region of RNase L monomers causes
RNase L dimerization and activates the C-terminal
nuclease domain. Activated RNase L cleaves
single-stranded (ss)RNA preferentially after UU and UA
dinucleotide motifs. [For a recent review of the 2-5A
system, see ref. (1).]
Although nucleoside modiﬁcations are common in RNA,
how this inﬂuences 2-5A system activity is unknown. RNA
contains more than 100 different modiﬁed nucleosides.
Nucleoside modiﬁcations are produced naturally during
RNA maturation and are introduced post-trans-
criptionally in a site-speciﬁc manner. Pseudouridine ()
is the most prevalent modiﬁed nucleoside found in RNA
(2,3). One function of  at speciﬁc locations in tRNA and
ribosomal RNA (rRNA) is to stabilize crucial secondary
structure (4). However, no physiologic role has been
identiﬁed for the majority of RNA modiﬁcation sites,
and the effect of nucleoside modiﬁcations on most
RNA-binding proteins has not been established.
In vitro transcribed RNA containing modiﬁed nucleo-
sides has been shown to be less stimulatory to several host
defense RNA sensors, including protein kinase R (PKR),
toll-like receptor (TLR)3, TLR7, TLR8 and retinoic acid-
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production of in vitro transcribed mRNA in which every
uridine is replaced by pseudouridine (-mRNA) and
found that protein expression from -mRNA is higher
than from unmodiﬁed in vitro transcribed mRNA (9),
and this enhanced translation is due in part to reduced
activation of PKR by -mRNA (6).
Here, we report that the presence of modiﬁed nucleo-
sides in RNA has two effects on the 2-5A pathway.
Certain unmodiﬁed in vitro transcribed mRNAs activate
OAS, resulting in rRNA cleavage and reduced translation.
Additionally, unmodiﬁed RNA is more rapidly cleaved by
activated RNase L. In contrast, RNAs containing certain
modiﬁed nucleosides fail to activate OAS and are resistant
to cleavage by RNase L. Modiﬁed RNA is therefore




Human embryonic kidney (HEK) 293T cells were obtained
from the American Type Culture Collection and were
cultured in DMEM supplemented with 2mM L-glutamine
(Life Technologies), 100 U/ml penicillin, 100mg/ml strepto-
mycin (Invitrogen) and 10% fetal calf serum (HyClone).
Immortalized wild-type (WT) and RNase L
 /  mouse em-
bryonic ﬁbroblasts (MEFs) were maintained in RPMI
medium supplemented with 2mM L-glutamine, 100U/ml
penicillin, 100mg/ml streptomycin and 10% fetal calf
serum. Oligo RNAs C11U2C7 and C112C7 were custom
synthesized (Dharmacon) and were 50-end-labeled using
[g-
32P]ATP (PerkinElmer) and T4 polynucleotide kinase
(New England Biolabs). Polyinosinic:polycytidylic acid
[poly(I:C)] was purchased from Sigma.
mRNA synthesis and puriﬁcation
RNAs were transcribed as previously described (7), using
linearized plasmids encoding ﬁreﬂy luciferase (pT7TS-
fLuc) or Renilla luciferase (pT7TS-Ren) and T7 RNA
polymerase (Megascript, Ambion). Capped mRNA was
generated by performing transcription in the presence of
cap analog 30-O-Me-m7G(50)ppp(50)G (New England
Biolabs). Metabolically labeled mRNA was generated by
performing transcription in the presence of [a-
32P]CTP
(PerkinElmer). All mRNAs were transcribed to contain
30nt-long 30-poly(A) tails. RNA containing modiﬁed nu-
cleosides was generated by substituting a modiﬁed nucleo-
side triphosphate [NTP derivatives of ,m
6A and s
2U
(TriLink)] for its cognate unmodiﬁed NTP in transcription
reactions, as described previously (7,9). Following tran-
scription, the template plasmids were digested with
Turbo DNase and RNAs were precipitated with 2.5M
lithium chloride at  20 C for 4h. RNAs were pelleted
by centrifugation, washed with 75% ethanol and then
reconstituted in nuclease-free water. The concentration
of RNA was determined by measuring the optical density
at 260nm. All RNA samples were analyzed by agarose gel
electrophoresis for quality assurance. RNA was high per-
formance liquid chromatography (HPLC) puriﬁed on an
RNASep cartridge (Transgenomic). Lack of double-
stranded contaminants in the puriﬁed RNA samples was
conﬁrmed by RNA dot–blot performed with dsRNA-
speciﬁc mAb J2 (English & Scientiﬁc Consulting Bt.).
In vitro OAS activation and measurement of
functional 2-5A
Recombinant hexahistidine-tagged human OAS1 p42 was
a gift of Rune Hartmann (University of Aarhus,
Denmark) (10). Recombinant human RNase L and
p3[20p50A]2A (trimer 2-5A) were prepared as described
(11,12). Dual-labeled ﬂuorescent probe 6-FAM-UUA
UCA AAU UCU UAU UUG CCC CAU UUU UUU
GGU UUA-BHQ-1 was custom synthesized by
Integrated DNA Technologies. In vitro OAS1 activation
was performed as described (13). Brieﬂy, 20mg/ml of
OAS1 was activated with 2.0mg/ml RNA for the indicated
time in buffer consisting of 20mM HEPES pH 7.5, 20mM
Mg(OAc)2, 20mM KCl, 1mM EDTA and 10mM ATP.
Reactions were stopped by heating to 95 C for 3min. Rate
of functionally active 2-5A produced was measured using
a ﬂuorescence resonance energy transfer (FRET) based
assay as described previously (14,15). Synthesized
p3[20p50A]2A (trimer 2-5A) (12) was puriﬁed using HPLC
and used for generating standard curves (13).
rRNA cleavage
One day prior to transfection, WT or RNase L
 /  MEF
cells were seeded into 96-well plates at a density of
5.0 10
4 cells/well and treated with 1000U/ml
interferon-aA/D (Sigma). Poly(I:C) or mRNAs were com-
plexed with lipofectin as described (7). Cells were exposed
to 50ml DMEM containing lipofectin-complexed RNA
(2.5mg) for 1h, which was then replaced with complete me-
dium and further cultured. At 3h post-transfection, total
RNA was recovered from cells using Trizol (Invitrogen).
RNA was separated by agarose gel electrophoresis,
stained with SybrGold reagent (Invitrogen) and detected
using UV ﬂuorescence and a GelDoc 2000 imager
(Bio-Rad Laboratories).
In vitro RNA cleavage by RNase L
Recombinant human RNase L was prepared as described
(14). For oligo RNAs, 12.5nM RNase L was activated on
ice with 100nM trimer 2-5A for 30min in RNase L
cleavage buffer (25mM Tris–HCl pH 7.4, 100mM KCl,
10mM MgCl2, 50mM ATP and 7mM b-mercapto-
ethanol). Then 100nM 50-end-labeled oligo RNA
[
32P]pC11U2C7 or [
32P]pC112C7 was added and reactions
were incubated at 30 C. At the indicated times, reactions
were stopped by the addition of urea-TBE loading buffer
(Bio-Rad) and heating to 95 C for 3min. Aliquots were
separated by 15% polyacrylamide gel electrophoresis, gels
were dried, and samples were imaged using a phosphor
storage screen (Molecular Dynamics) and detected using
a Typhoon PhosphorImager (GE Healthcare). Cleavage
of mRNA was performed similarly, using 10nM RNase
L, 10nM trimer 2-5A and 100nM of metabolically
32P-labeled ﬁreﬂy luciferase mRNA. Reactions were
stopped by heating to 95 C for 5min. The mRNA was
9330 Nucleic Acids Research, 2011,Vol.39, No. 21recovered by phenol:chloroform extraction and detected
by northern blotting.
RNA stability in rabbit reticulocyte lysate
Equal mass (25ng/ml) or equal molar (40mM) mRNAs-
encoding ﬁreﬂy and Renilla luciferases were incubated in
15ml rabbit reticulocyte lysate (RRL) (Promega) at 30 C.
At the indicated times, a 2ml aliquot was removed and the
RNA was recovered using Trizol for subsequent detection
by northern blotting.
RNA stability in cell culture
HEK293T, WT MEF or RNase L
 /  MEF cells were
nucleofected with 5mg mRNA using nucleofector program
T-020 and nucleofector V kit (Lonza). After 15min recov-
ery in RPMI, cells were plated in complete media and
incubated at 37 C. At the indicated time, RNA was re-
covered from cells using Trizol for subsequent detection
by northern blotting.
Northern blotting
RNA was isolated from RRL or cells using Trizol.
Samples were processed and analyzed on northern blots
as previously described (16). Probes were derived from
plasmids and were speciﬁc for the coding region of
ﬁreﬂy luciferase or Renilla luciferase.
Half-life calculation
After performing northern blots, images were scanned
from ﬁlm and ImageJ (version 1.44 p) was used to measure
the density of the band corresponding to the full-length
mRNA. For each data point, the log10 was taken and the
values were plotted as a function of time. The slope of best
ﬁt line (k) was used to calculate the mRNA half-life using
the equation t1/2=0.693/k (17).
Detection of reporter proteins in RNA-transfected cells
Cells were seeded into 96-well plates at a density of
2–5 10
4 cells/well one day prior to transfection. Cells
were exposed to 50ml DMEM containing lipofectin-
complexed RNA (0.25mg) for 1h, which was then replaced
with complete medium and further cultured. Cells were
lysed in 25ml Fireﬂy-, Renilla- or Dual-Luciferase-
speciﬁc lysis reagents (Promega). Aliquots of 2ml were
assayed with the corresponding enzyme substrates
(Promega) and a LUMAT LB 950 luminometer
(Berthold) at a 10-s measuring time.
Translation of mRNA in mice
All mice were cared for according to institutional guide-
lines at the University of Pennsylvania under a protocol
approved by the Institutional Animal Care and Use
Committee. WT C57Bl/6 (NCI) and C57Bl/6 backcrossed
RNase L
 /  mice at 9–16 weeks of age received tail vein
injections of 1mg RNA complexed with lipofectin in 60ml
DMEM. At the indicated time, mice were sacriﬁced and
spleens were isolated. Each spleen was bisected and spleen
fragments were homogenized in 200ml cell culture lysis
reagent (Promega). Luciferase activity was detected in a
40ml aliquot of lysed spleen using 200ml luciferase assay
substrate (Promega) and a LUMAT LB 950 luminometer
at a 10-s measuring time.
Immunoprecipitation
HEK293T cells were seeded into 96-well plates at a density
of 5.0 10
4 cells/well 1 day prior to transfection. Cells
were exposed to 50ml DMEM containing lipofectin-
complexed RNA (0.25mg) for 1h, which was then replaced
with complete medium and further cultured. Cells were in-
cubated in methionine/cysteine-free medium (Invitrogen)
for 1h, then pulsed with complete medium supplemented
with
35S-methionine/cysteine (140mCi/ml) (PerkinElmer)
for 3h prior to lysis in 50ml RIPA buffer supplemented
with protease inhibitor cocktail (Sigma). Renilla luciferase
was immunoprecipitated from lysates using an anti-
Renilla luciferase antibody (PM047, Medical & Biological
Laboratories) and protein G-coated Dynabeads
(Invitrogen) and separated by 15% polyacrylamide gel
electrophoresis. Gels containing the labeled samples were
treated with 1M sodium salicylate, dried and a ﬂuorogram
was generated by exposure to BioMax MS ﬁlm (Kodak).
Statistical analysis
All data are reported as mean±standard error of the
mean (SEM). Statistical differences between treatment
groups were calculated by the Student’s t-test using
Microsoft Excel. For all statistical testing, a P<0.05
was considered signiﬁcant.
RESULTS
RNA containing nucleoside modiﬁcations activates OAS
less than unmodiﬁed RNA
We ﬁrst compared the activation of puriﬁed human OAS1
by unmodiﬁed RNA or RNA with identical sequence con-
taining the modiﬁed nucleosides , N
6-methyladenosine
(m
6A) or 2-thiouridine (s
2U). The amount of functionally
active 2-5A (trimer or higher) produced was quantiﬁed
using a FRET-based RNase L activation assay (12,13).
The unmodiﬁed RNA efﬁciently activated OAS1. In
contrast, RNA containing ,m
6Ao rs
2U were poor acti-
vators of OAS and did not induce production of function-
ally active 2-5A (Figure 1). Because  is the most
prevalent modiﬁed nucleoside (2,3) and has also been
shown to reduce the RNA activation of other RNA
sensors (5–8), subsequent experiments focused on the
comparison of unmodiﬁed RNA to -containing RNA
with identical sequence.
Pseudouridine-containing RNA induces less rRNA
cleavage than unmodiﬁed RNA
OAS activation by unmodiﬁed RNA leads to activation of
RNase L, which mediates the effector function of the 2-5A
system by cleaving ssRNA. RNase L-mediated cleavage at
exposed loops of rRNAs in intact ribosomes results in
well-deﬁned cleavage patterns in rRNA (18). Therefore,
the integrity of rRNA following RNA transfection was
examined. Lipofectin-complexed RNA was transfected
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 /  MEF cells, and total RNA was
subsequently recovered and examined by agarose gel elec-
trophoresis and UV imaging. Cells mock transfected with
no RNA were included as a negative control. In WT cells,
delivery of unmodiﬁed in vitro transcribed RNA induced
cleavage of rRNA, but signiﬁcantly less rRNA was cleaved
when the transfected RNA contained . Transfection
of the same set of RNAs into RNase L
 /  MEF cells
did not generate the speciﬁc rRNA degradation proﬁle
(Figure 2).
RNase L cleaves uridine-containing RNA more readily
than )-containing RNA
Activated RNase L cleaves preferentially after UpNp in
ssRNA. Therefore, to compare the ability of RNase L to
cleave -containing RNA, puriﬁed recombinant human
RNase L was activated with trimer 2-5A and mixed with
50-[
32P] end-labeled oligo RNA containing a single RNase
L cleavage site (C11U2C7 or C112C7). The oligo RNA
containing unmodiﬁed uridine was rapidly cleaved, while
there was no signiﬁcant cleavage of the oligo RNA con-
taining  (Figure 3A and B). Full-length ﬁreﬂy luciferase
mRNA metabolically labeled with
32P was then analyzed
for cleavage by RNase L. Both unmodiﬁed and -RNA
could be cleaved by RNase L. However, consistent with
the results obtained with oligo RNAs, -containing RNA
was cleaved less efﬁciently by RNase L than unmodiﬁed
RNA (Figure 3C).
Nucleoside-modiﬁed RNA has an increased half-life
We next examined the stability of unmodiﬁed and
-containing RNA by northern blot analysis. Both un-
modiﬁed and -RNA were equally stable at room
temperature through experimental time courses and indef-
initely in storage at  20 C. Unmodiﬁed and -RNAs
were added to RRL or transfected to HEK293T cells.
When transfecting cells using cationic lipids, a portion of
RNA complexed with transfection reagents persist as an
extracellular, nuclease-protected fraction. Therefore, for
these experiments, we used nucleofection to deliver
naked RNA and conﬁrmed the rapid degradation of extra-
cellular RNA by serum nucleases in the culture media.
Total RNA was subsequently re-isolated and aliquots
were examined by northern blot to compare degradation
rates of the reporter RNAs. Two reporter RNAs, ﬁreﬂy
and Renilla luciferase, were studied simultaneously to
ensure that stability differences were not a result of differ-
ences in delivery conditions. -modiﬁed RNAs had longer
half-lives than unmodiﬁed RNAs in RRL (Figure 4A).
Similarly, in HEK293T cells the half-life of -modiﬁed
ﬁreﬂy luciferase RNA increased  2-fold to 6.1h
compared to 3.2h for unmodiﬁed RNA (Figure 4B).
Subsequently, the inﬂuence of RNase L on the stability
of unmodiﬁed and -containing RNA was also compared
using RNase L
 /  MEF cells. As in HEK293T cells, the
Figure 2. Induction of rRNA cleavage by in vitro transcribed RNA.
Unmodiﬁed (U) or -containing RNA encoding ﬁreﬂy luciferase was
complexed to lipofectin and delivered to WT or RNase L
 /  MEF
cells, as was a no RNA ( ) control. At 3h following transfection,
total RNA was recovered from cells. RNA aliquots were separated in
an agarose gel and visualized by UV ﬂuorescence. Arrowheads indicate
RNase L-speciﬁc rRNA cleavage products. Bar graph above bands
shows densitometric measurement±SD of the ratio of cleavage
products to uncleaved 18S rRNA, normalized to cells not treated
with RNA. Representative data from one of three independent experi-
ments is shown.
Figure 1. OAS activation by RNA containing modiﬁed nucleosides.
Puriﬁed human OAS1 p42 was activated with RNAs containing
either unmodiﬁed (U) or the indicated nucleoside modiﬁcations and
the functionally active 2-5A produced was quantiﬁed using a
FRET-based assay as described in ‘Materials and Methods’ section.
Data shown are mean of three replicates.
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covered from cell culture and ﬁreﬂy and Renilla luciferase
RNA were assessed by northern blot. In both WT and
RNase L
 /  MEF cells, -modiﬁed RNA half-life was
increased by 50% to 3.8h compared to 2.5h for unmodi-
ﬁed RNA (Figure 4C).
Translational advantage of )-RNA is reduced in the
absence of RNase L
Considering that -modiﬁcation of RNA reduced activa-
tion of OAS1 and RNA induced rRNA degradation, and
Figure 4. Stability of -containing RNA. Unmodiﬁed (U) or
-containing RNAs encoding ﬁreﬂy or Renilla luciferases were mixed
1:1 and either added to RRL (A) or nucleofected to HEK293T cells
(B). At the indicated time points, RNA was recovered and detected by
northern blotting. Radiolabeled DNA probes corresponding to the
coding sequence of ﬁreﬂy and Renilla luciferases were mixed prior to
northern hybridization (A) or used separately to probe duplicate
northern blots from aliquots of the recovered RNA (B). Bar graphs
above the images show densitometric measurement of the uncleaved
ﬁreﬂy luciferase mRNA. Data shown is representative of at least ﬁve
independent experiments. (C) Unmodiﬁed (U) or -containing in vitro
transcribed RNA encoding ﬁreﬂy luciferase was delivered to WT or
RNase L
 /  MEF cells by nucleofection. Cells were lysed at 0.2, 1,
3, 6 or 24h following transfection, total RNA was recovered, and
luciferase RNA was assessed by northern blotting. Radiolabeled
DNA corresponding to the ﬁreﬂy luciferase coding sequence was used
as probe. Bar graph above bands shows densitometric measurement of
the uncleaved RNA. Representative data is shown from one of three
independent experiments.
Figure 3. Cleavage of -containing RNA by RNase L. Puriﬁed RNase
L was activated on ice by trimer 2-5A prior to mixing with RNA
substrates. (A) Cleavage of oligo RNAs [
32P]pC11U2C7 (UU) or
[
32P]pC112C7 () by RNase L. Reactions were stopped at the
indicated time by addition of loading buffer, and reactions were
separated by PAGE and visualized by phosphor-storage radiography.
Representative data from one of three independent experiments is
shown. (B) Quantiﬁcation of band intensities. Values were normalized
to the values obtained in the 30min reaction not containing RNase L.
Data represents average±SEM of n=3 experiments. Asterisks
indicate P<0.05. (C) Cleavage of metabolically [
32P]-labeled unmodi-
ﬁed (U) or -containing ﬁreﬂy luciferase mRNA by RNase L.
Reactions were stopped at indicated times. Aliquots of isolated RNA
from each reaction were separated by PAGE and visualized by
phosphor-storage radiography. Representative data from one of three
independent experiments is shown.
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ﬁciently, we asked how the absence of RNase L inﬂuences
translation of unmodiﬁed and -containing mRNA.
Thus, mRNAs encoding luciferase were transfected into
WT and RNase L
 /  MEF cell lines and translation was
assessed by measuring luciferase activity. In WT cells,
more protein was translated from the -containing
mRNA than from the unmodiﬁed mRNA. In the RNase
L
 /  cell line, there was lower level translation of both
mRNAs and the translational advantage of -mRNA
over unmodiﬁed mRNA was dramatically reduced
(Figure 5A).
A similar pattern of translation occurred in the spleens
of mice following injection of mRNA. Either WT C57Bl/6
or RNase L
 /  mice were given lipofectin-complexed
luciferase mRNA by tail vein injection. Luciferase
activity was assessed in spleen lysate 4h later. In WT
mice, -containing mRNA was translated at higher
levels than unmodiﬁed mRNA. In RNase L
 /  mice,
translation of -containing mRNA reached the same
level as observed in WT mice, but translation of unmodi-
ﬁed mRNA was increased relative to WT (P<0.05),
(Figure 5B).
Translation of pseudouridine-containing mRNA continues
for a longer time than unmodiﬁed mRNA
Having seen that the presence of modiﬁed nucleosides in
mRNA increases its half-life and translation efﬁciency, we
compared the translation over time, to determine how
modiﬁed nucleosides inﬂuence the duration of translation.
RNA was complexed to lipofectin and delivered to cells
that were subsequently pulsed with
35S-methionine/cysteine
for 3h at 1, 21 and 45h post-transfection. Translation of the
mRNA was assessed by immunoprecipitating the encoded
Renilla luciferase protein and measuring
35S incorpor-
ation. There was a higher level of total translation of
-containing mRNA at each time point (Figure 6A),
and ongoing translation of -containing mRNA
continued after at least 48h when detectable translation
of unmodiﬁed mRNA ceased (Figure 6B).
DISCUSSION
We investigated how the enzymes of the 2-5A system
interact with RNA and the role that modiﬁed nucleosides
play in altering activation and effector function. Our data
show that in vitro transcribed unmodiﬁed RNA activates
OAS1, but this activation is reduced when the RNA
contains modiﬁed nucleosides. OAS activation by un-
modiﬁed RNA leads to RNase L-mediated rRNA
cleavage, which is reduced by -RNA. Furthermore,
RNase L cleaves unmodiﬁed RNA more efﬁciently than
Figure 6. Translation of -containing mRNA in cell culture.
Unmodiﬁed (U) and -containing mRNA were complexed to lipofectin
and delivered to HEK293T cells. (A) Renilla luciferase activity was
assessed in aliquots of cell lysate. Data displayed is mean±SEM
from four replicates, each performed in duplicate. (B) Cells were
pulsed for the last 3h with
35S-methionine/cysteine prior to lysis at
the indicated time points. Renilla luciferase protein was immunopre-
cipitated from cell lysates, separated by PAGE and then visualized by
ﬂuorography. Data shown is one of four replicates and is representative
of three independent experiments.
Figure 5. Translation of unmodiﬁed and -containing mRNA in WT
and RNase L
 /  cells and mice. Unmodiﬁed (U) or -containing
in vitro transcribed mRNA encoding ﬁreﬂy luciferase was complexed
to lipofectin and delivered to WT and RNase L
 /  MEF cells or mice.
Luciferase activity was measured in aliquots of cell or spleen lysate. (A)
MEF cells lysed 5h following transfection. Values presented are
luciferase relative light units (RLU) in 2ml of the total 20ml cell
lysate. Error bars indicate SEM of quadruplicate wells from one rep-
resentative of at least six independent experiments. (B)
Lipofectin-complexed mRNA was delivered by tail vein injection into
mice. Mice were sacriﬁced at 4h post-transfection and their spleens
were homogenized in lysis buffer. Values presented are luciferase
RLU in 1/5 of the total 200ml spleen lysate. Error bars represent
SEM of n=3 mice.
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 /  MEF
cells and RNase L
 /  mice demonstrate that translation of
unmodiﬁed mRNA is decreased in the presence of the
intact 2-5A system, but that the translation level of
-mRNA is largely independent of the 2-5A system. In
addition, the presence of  increases the half-life of in vitro
transcribed RNA in cells and lysates. Finally, we demon-
strate that -containing mRNA is translated for a longer
duration than unmodiﬁed mRNA.
RNA sensing in the 2-5A pathway is performed by the
OAS family of proteins. Activation of OAS was originally
characterized as requiring >8bp of uninterrupted helix in
>30-bp long dsRNA (19), but subsequently other struc-
tures with signiﬁcant single-strandedness have been
proven to be potent OAS activators, including aptamers
(20), viral RNAs (21–24) and some cellular RNAs (13,25).
However, dsRNA generated from homopolymers contain-
ing 20-O-methylated nucleosides (26,27) or 5-methyl-
uridines (28) did not activate OAS. Here, we report that
unmodiﬁed in vitro transcribed RNA activated OAS1 to
generate 2-5A, but this was substantially reduced when
RNA contained ,m
6Ao rs
2U. Recently, the consensus
sequence nnWWnnnnnnnnnWGn (W=U or A) was
demonstrated to be important for OAS1 activation by
dsRNA, and this interaction was dependent on the
minor groove and free OH groups on the critical base
pairs (29). The requirement that three out of the four
critical base pairs in this sequence must be U:A highlights
the importance of uridine for OAS1 activation. However,
pseudouridine forms hydrogen bounds with adenosine in
the same manner that uridine does (Figure 7), and the
imino group of  is oriented toward the major groove
(30), so how  disrupts OAS1 activation remains unclear.
The presence of  stabilizes secondary structure and adds
rigidity to both ss and dsRNA [reviewed in (4)]. In this
capacity,  could affect OAS activation by altering the
equilibrium structure of the RNA, rather than directly
affecting OAS binding.
Activation of OAS leads to production of 2-5A, which
binds to the latent endoribonuclease RNase L, the effector
enzyme of the 2-5A pathway. Activated RNase L cleaves
various ssRNA including speciﬁc sites of rRNAs access-
ible in the intact ribosome, resulting in RNase L-speciﬁc
cleavage products visible by gel electrophoresis (18). In
WT MEF, unmodiﬁed RNA induced rRNA cleavage,
which was reduced if RNA contained . However, none
of the RNAs caused rRNA cleavage in RNase L
 /  cells,
conﬁrming that the 2-5A system is required for
RNA-induced rRNA cleavage. High levels of 2-5A result
in global rRNA cleavage by RNase L (31), and when sus-
tained ultimately lead to apoptosis (32,33). In comparison,
the level of rRNA cleavage induced here by transfection of
in vitro transcribed RNA is relatively small, and may not
be expected to induce high levels of apoptosis. On the
other hand, this level of rRNA cleavage is sufﬁcient to
have a profound impact on translation of the reporter
mRNA. We propose that unmodiﬁed RNA induces local
OAS and RNase L activation, as demonstrated with viral
RNAs and ssRNA covalently linked to dsRNA (34,35).
Accordingly, locally activated RNase L cleavage likely
reduces translation of unmodiﬁed mRNA through local
cleavage of rRNA without inducing global rRNA
cleavage and apoptosis.
The presence of  has been shown to enhance the sta-
bility of RNA secondary structures, but has not previously
been demonstrated to cause resistance to nucleases. RNA
containing  was cleaved efﬁciently by RNase A, RNase
H (36), RNase T1, RNase T2, nuclease P1 and snake
venom phosphodiesterase, although there is some indica-
tion that pancreatic diesterase and snake venom phospho-
diesterase may cleave -RNA with reduced efﬁciency (37).
A previous report based on cleavage of a C11N2C7 oligo
RNA showed that RNA containing 20-deoxy-20-
a-ﬂuorouridine was bound by RNase L but cleaved slowly,
whereas RNA containing 20-O-methyluridine was not
bound by RNase L (38). Here, we used a similar approach
and demonstrated that puriﬁed RNase L readily cleaved
the oligo ssRNA C11U2C7 but not when the cleavage
site contained . We also extended those ﬁndings to the
examination of long in vitro transcribed RNA and showed
that unmodiﬁed RNA was cleaved by puriﬁed RNase L,
but cleavage of -RNA proceeded more slowly. The
cleavage of -RNA despite inactivity toward C112C7 is
not surprising considering the substrate speciﬁcity of
RNase L. RNase L cleaves preferentially after UpNp,
with highest activity following UU, UA and AU, but it
is also capable of cleaving RNA following dinucleotide
motives that avoid U (e.g. AA, AC and CA) (39–41).
We also examined the effect of -modiﬁcation on the
stability of in vitro transcribed RNA. In RRL and in cell
Figure 7. Structures and base pairing of uridine and pseudouridine. In
pseudouridine, uracil is linked to ribose via C5 instead of the N1
linkage found in uridine (C5 and N1 are indicated in bold type).
Hydrogen bonds between adenosine and uridine or pseudouridine are
indicated by dotted lines. Additional hydrogen bonding potential of
pseudouridine is indicated by dashed arrow.
Nucleic Acids Research, 2011,Vol.39, No. 21 9335culture, -RNA was degraded more slowly than unmodi-
ﬁed RNA. Previous experiments also suggested that
-RNA is retained longer following injection in mice
(9). Despite the rapid cleavage of unmodiﬁed RNA by
RNase L in vitro, the half-life of unmodiﬁed RNA did
not increase to the level of -RNA in RNase L
 /  cells.
This suggests that in addition to RNase L, other intracel-
lular nucleases also cleave unmodiﬁed RNA more efﬁ-
ciently than -containing RNA.
As seen in previous reports (6,9), in WT cells, there was
signiﬁcantly higher translation of -mRNA than unmodi-
ﬁed mRNA. In contrast, in RNase L
 /  MEF cells the
translational advantage of -mRNA over the unmodiﬁed
mRNA was limited. Similarly, the translational advantage
of -mRNA was reduced in RNase L
 /  mice relative to
WT mice. Notably, however, the absolute translation level
of -mRNA remained equal in WT and RNase L
 / 
mice, while the translation of unmodiﬁed mRNA
increased in RNase L
 /  mice. This indicates that
neither the presence of RNase L nor -mRNA alone sig-
niﬁcantly affects translation of -mRNA, but rather that
unmodiﬁed RNA causes translational inhibition through
RNase L activation. Moreover, these results are consistent
with the in vitro activation of OAS1 by unmodiﬁed RNA
that we observed. Furthermore, -mRNA continued to be
actively translated for a longer duration than unmodiﬁed
mRNA. In RNase L
 /  cells and mice, the translational
advantage of -mRNA is reduced, despite the observation
that the absence of RNase L in cells does not signiﬁcantly
alter the stability of either U-RNA or -mRNA.
Therefore, we propose that in cells the mechanism by
which the 2-5A system enhances translation of
-mRNA is not primarily through reduced degradation
of the -mRNA itself, but instead through decreased
rRNA cleavage resulting from diminished OAS activation.
Thus, OAS activation by unmodiﬁed mRNA results in
RNase L activation, which reduces translation due to
rRNA cleavage rather than through cleavage of the
activating transfected mRNA.
In addition to viral RNA, select cellular mRNAs from
prostate cancer cells have been shown to activate OAS
(13). Additionally, cleavage of cellular and viral RNAs
by RNase L produces short RNAs, which can activate
the cytoplasmic RNA sensor RIG-I, leading to interferon
production (42–44). The presence and effects of modiﬁed
nucleosides in these RNase L-generated short RNAs has
not been investigated. Because RNA containing modiﬁed
nucleosides activates OAS less and is less efﬁciently
cleaved by RNase L, if viral infection or cancer develop-
ment were to alter the level of nucleoside modiﬁcation, it
could lead to modiﬁed RIG-I activation and ultimately
change immune responsiveness and disease progression.
Consistent with this possibility, some viral mRNAs are
hyper-methylated compared to mammalian mRNA
(45,46). Viral-encoded 20-O-methyltransferases extensively
modify the 50-ends of their capped mRNA. This modiﬁ-
cation is critical for the virus to avoid interferon induction
and evade detection by the immune system. (47,48).
Additionally, a recent study of non-small-cell lung
cancer identiﬁed the upregulation of small nucleolar
RNAs (snoRNAs), which function in directing
pseudouridylation and 20-O-methylation of RNA (49).
Nucleases play a central role in host defense through
destruction of pathogenic nucleic acids. The 2-5A system
functions to detect and degrade danger-associated intra-
cellular RNAs. Activation of RNase L also leads to
reduced translation due to rRNA cleavage and when sus-
tained, results in apoptosis, further limiting replication of
the pathogens. Here, we identify that some unmodiﬁed
RNAs serve as a molecular pattern recognized by OAS
and RNase L. The 2-5A system activity is decreased
when RNA contains nucleoside modiﬁcations, which
reduce both OAS activation and cleavage by RNase L.
Other RNA sensors, including PKR, TLR3, TLR7,
TLR8 and RIG-I (5–8) also exhibit reduced activation
by RNA containing modiﬁed nucleosides. Therefore, this
work supports the proposal made by us and others that
RNA sensors recognize certain RNAs that contain un-
modiﬁed nucleosides as a danger-associated molecular
pattern, as part of the extensive system of innate host
defenses against pathogenic RNA, but that nucleoside
modiﬁcation suppresses RNA immunogenicity.
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